London, Feb 27, 2026, 08:49 GMT — Regular session
- HSBC edged up 0.4% at the open in London, with the stock sticking close to its recent peak.
- HSBC’s boosted profitability goal and its approach to capital returns are still being processed by investors.
- HSBC’s Singapore life insurance manufacturing arm could be up for sale, drawing attention.
HSBC inched 0.4% higher to 1,404 pence early Friday in London, holding close to the week’s peak following that brisk post-earnings jump.
The move is drawing attention as investors look to see if HSBC’s updated outlook will push the stock higher, now that costs and capital returns are front and center again. After annual profit came in ahead of forecasts, the bank lifted its return on tangible equity target—seen as a key yardstick for profitability.
A new trigger emerged just a day after. HSBC has started the sale process for its Singapore life insurance product manufacturing division, aiming for a price tag north of $1 billion, according to three sources familiar with the situation, Reuters reported.
HSBC posted full-year pretax profit of $29.9 billion for 2025, a 7% dip after accounting for one-off charges. The board signed off on a fourth interim dividend of $0.45 per share, bringing the annual payout to $0.75.
During its investor presentation, the bank outlined 2026 goals, aiming for banking net interest income (NII) of no less than $45 billion, and cost growth on a target basis pegged around 1%. The NII figure reflects the difference between loan earnings and deposit costs.
Some investors are buying into the wealth angle. “The bank has slimmed down to focus on fewer regions, and to pay greater attention to wealthier individuals,” Russ Mould, investment director at AJ Bell, said this week after HSBC’s strong results sent shares higher. Reuters
European stocks are on track for yet another month in the green, bolstered by a run of upbeat corporate news—HSBC’s update among them. Still, the mood in bank shares remains jumpy, with traders keeping a close eye on credit risk flare-ups across the industry.
Signs of risk are emerging in other UK lenders, too. Barclays shares dropped Friday, as investors reacted to a report highlighting possible losses from the collapse of a UK mortgage provider—stirring fresh worries about exposures that aren’t easy to untangle fast.
At HSBC, the risks are largely internal: a harsher rate environment could pressure NII, while rising technology costs add further strain. Asset sales might also disappoint on price. There’s also the ongoing exposure to Asian markets, where weaker growth or fresh property turmoil could hit credit quality.
Investors will be digging into the latest annual disclosures, with a sharp eye on capital, risk-weighted assets and any moves to shed businesses. They’re also watching for concrete word on the Singapore insurance review, plus clues on when share buybacks might get the green light.
